Abbott India Limited (ABBOTINDIA.BO)

INR 28764.0

(2.24%)

Operating Expenses Summary of Abbott India Limited

  • Abbott India Limited's latest annual operating expenses in 2023 was 5.98 Billion INR , down -51.65% from previous year.
  • Abbott India Limited's latest quarterly operating expenses in 2024 Q1 was 1.59 Billion INR , up 114.36% from previous quarter.
  • Abbott India Limited reported a annual operating expenses of 12.38 Billion INR in annual operating expenses 2022, up 0.93% from previous year.
  • Abbott India Limited reported a annual operating expenses of 12.26 Billion INR in annual operating expenses 2021, up 17.38% from previous year.
  • Abbott India Limited reported a quarterly operating expenses of 1.57 Billion INR for 2023 Q4, down -45.65% from previous quarter.
  • Abbott India Limited reported a quarterly operating expenses of 3.17 Billion INR for 2023 Q1, down -0.82% from previous quarter.

Annual Operating Expenses Chart of Abbott India Limited (2023 - 2004)

Historical Annual Operating Expenses of Abbott India Limited (2023 - 2004)

Year Operating Expenses Operating Expenses Growth
2023 5.98 Billion INR -51.65%
2022 12.38 Billion INR 0.93%
2021 12.26 Billion INR 17.38%
2020 10.45 Billion INR -2.37%
2019 10.7 Billion INR 7.5%
2018 9.95 Billion INR 12.95%
2017 8.81 Billion INR 11.64%
2016 7.89 Billion INR 10.45%
2015 7.14 Billion INR 15.78%
2014 6.17 Billion INR 8.41%
2013 5.69 Billion INR 21.4%
2012 4.69 Billion INR 21.9%
2011 3.84 Billion INR 51.66%
2010 2.53 Billion INR 75.27%
2009 1.44 Billion INR 17.67%
2008 1.23 Billion INR 42.92%
2007 860.9 Million INR 23.0%
2006 699.9 Million INR 13.12%
2005 618.7 Million INR 246.61%
2004 178.5 Million INR 0.0%

Peer Operating Expenses Comparison of Abbott India Limited

Name Operating Expenses Operating Expenses Difference
Cipla Limited 59.21 Billion INR 89.891%
Gland Pharma Limited 3.86 Billion INR -55.018%
GlaxoSmithKline Pharmaceuticals Limited 4.35 Billion INR -37.381%
Kopran Limited 859.54 Million INR -596.435%
Marksans Pharma Limited 3.28 Billion INR -81.982%
NGL Fine-Chem Limited 816.16 Million INR -633.456%
Pfizer Limited 4.33 Billion INR -38.02%
Sanofi India Limited 3.69 Billion INR -62.096%
SMS Pharmaceuticals Limited 370.89 Million INR -1513.996%